Comparison of the predictive value of GlycA and other biomarkers of inflammation for total death, incident cardiovascular events, noncardiovascular and noncancer inflammatory-related events, and total cancer events

Clinical Chemistry

Volumn 62, Issue 7, 2016, Pages 1020-1031

  Duprez, Daniel A ^a   Otvos, James ^b   Sanchez, Otto A ^a   Mackey, Rachel H ^c   Tracy, Russell ^d   Jacobs, David R ^e  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b LABORATORY CORPORATION OF AMERICA   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; D DIMER; GLYCAN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH SENSITIVITY C REACTIVE PROTEIN; INTERLEUKIN 6; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; ATTRIBUTABLE RISK; BLOOD SAMPLING; CANCER INCIDENCE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CONTROLLED STUDY; DEATH; DEATH CERTIFICATE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LIPID BLOOD LEVEL; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE; PREDICTION; PREDICTIVE VALUE; PROBABILITY; RESPIRATORY TRACT DISEASE; RISK FACTOR; SEPTICEMIA; ALGORITHM; ATHEROSCLEROSIS; BLOOD; COMPARATIVE STUDY; INFLAMMATION; MIDDLE AGED; NEOPLASM; VERY ELDERLY;

ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; ALGORITHMS; ATHEROSCLEROSIS; BIOMARKERS; DEATH CERTIFICATES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEOPLASMS; PREDICTIVE VALUE OF TESTS;

EID: 84976486058     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2016.255828     Document Type: Article

References (33)

1. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008;5: E203.
2. Nordell AD, McKenna M, BorgesA? H, Duprez D, Neuhaus J, Neaton JD, et al. Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation. J Am Heart Assoc 2014;3: E000844.
3. Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005;352: 1685-95.
4. Chan DS, Bandera EV, Greenwood DC, Norat T. Circulating C-reactive protein and breast cancer risk: Systematic literature review and meta-analysis of prospective cohort studies. Cancer Epidemiol Biomarkers Prev 2015; 24: 1439-49.
5. Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet 2010;375: 132-40.
6. Emerging Risk Factors Collaboration. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012;367: 1310-20.
7. Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review. PLoS Med 2008;5: E78.
8. Jeyarajah EJ, Cromwell WC, Otvos JD. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 2006;26: 847-70.
9. Otvos JD, Shalaurova I, Wolak-Dinsmore J, Connelly MA, Mackey RH, Stein JH, Tracy RP. GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation. Clin Chem 2015;61: 714-23.
10. Bell JD, Brown JC, Nicholson JK, Sadler PJ. Assignment of resonances for 'acute-phase' glycoproteins in high resolution proton NMR spectra of human blood plasma. FEBS Lett 1987;215: 311-15.
11. Marino K, Bones J, Kattla JJ, Rudd PM. A systematic approach to protein glycosylation analysis: A path through the maze. Nat Chem Biol 2010;6: 713-23.
12. Akinkuolie AO, Buring JE, Ridker PM, Mora S. A novel protein glycan biomarker and future cardiovascular disease events. J Am Heart Assoc 2014;3: E001221.
13. Akinkuolie AO, Pradhan AD, Buring JE, Ridker PM, Mora S. Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 2015;35: 1544-50.
14. Gruppen EG, Riphagen IJ, Connelly MA, Otvos JD, Bakker SJ, Dullaart RP. GlycA, a pro-inflammatory glycoprotein biomarker, and incident cardiovascular disease: Relationship with C-reactive protein and renal function. PLoS One. 2015;10: E0139057.
15. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, et al. Multi-Ethnic Study of Atherosclerosis: Objectives and design.AmJ Epidemiol 2002;156: 871-81.
16. Duprez DA, Otvos J, Tracy R, Feingold K, Greenland P, Gross MD, et al. High density lipoprotein subclasses and non-cardiovascular, non-cancer chronic inflammatory-related events versus cardiovascular events: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc 2015;4: E002295.
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130: 461-70.
18. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342: 836-43.
19. Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: Clinical importance. Curr Probl Cardiol 2004;29: 439-93.
20. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999;106: 506-12.
21. Carriere I, Dupuy AM, Lacroux A, Cristol JP, Delcourt C; Pathologies Oculaires Lie?es à l'Age Study Group. Biomarkers of inflammation and malnutrition associated with early death in healthy elderly people. J AmGeriatr Soc 2008;56: 840-6.
22. Agorastos A, Hauger RL, Barkauskas DA, Moeller- Bertram T, Clopton PL, Haji U, et al. Circadian rhythmicity, variability and correlation of interleukin-6 levels in plasma and cerebrospinal fluid of healthy men. Psychoneuroendocrinology 2014;44: 71-82.
23. Henry OF, Blacher J, Verdavaine J, Duviquet M, Safar ME. Alpha 1-acid glycoprotein is an independent predictor of in-hospital death in the elderly. Age Ageing 2003;32: 37-42.
24. Wensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, Shah T, et al. Association between C reactive protein and coronary heart disease: Mendelian randomisation analysis based on individual participant data. BMJ 2011;342: D548.
25. Fischer K, Kettunen J, Wu? rtz P, Haller T, Havulinna AS, Kangas AJ, et al. Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of allcause mortality: An observational study of 17,345 persons. PLoS Med 2014;11: E1001606.
26. Leitsalu L, Haller T, Esko T, Tammesoo ML, Alavere H, Snieder H, et al. Cohort Profile: Estonian Biobank of the Estonian Genome Center, University of Tartu. Int J Epidemiol 2015;44: 1137-47.
27. Vartiainen E, Laatikainen T, Peltonen M, Juolevi A, M?nistö S, Sundvall J, et al. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 2010;39: 504-18.
28. Chung CP, Ormseth MJ, Connelly MA, Oeser A, Solus JF, Otvos JD, et al. GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus. Lupus 2016;25: 296-300.
29. Ormseth MJ, Chung CP, Oeser AM, Connelly MA, Sokka T, Raggi P, et al. Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis. Arthritis Res Ther 2015;17: 117.
30. Ritchie SC, Wurtz P, Nath AP, Abraham G, Havulinna AS, Fearnley LG, et al. The Biomarker GlycA Is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection. Cell Systems 2015;1: 293-301.
31. Inouye M, Kettunen J, Soininen P, Silander K, Ripatti S, Kumpula LS, et al. Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol Syst Biol 2010;6: 441.
32. Raitakari OT, Juonala M, Rnemaa T, Keltikangas- Jvinen L, Ren L, Pietik?nen M, et al. Cohort profile: The cardiovascular risk in Young Finns Study. Int J Epidemiol 2008;37: 1220-26.
33. Pinho SS, Reis CA. Glycosylation in cancer: Mechanisms and clinical implications. Nat Rev Cancer 2015;15: 540-55.